sophoflavescenol (CJ)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namesophoflavescenol (CJ)

Drug Alias NamesophoflavescenolcGMP PDE 5 inhibitor (CJ)sophoflavescenol (Cheil Je Dang)cGMP PDE 5 inhibitor (Cheil Je Dang)

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionPhosphodiesterase 5A inhibitors

TargetsPhosphodiesterase 5A

Therapy Area/IndicationsErectile Dysfunction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCj Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCj Corp

Active IndicationsN/A

Inactive IndicationsErectile Dysfunction

ATC CodeN/A